Details for 2019722333

Up to date per 01.04.2026

Actions

Title / Product Name

APIXABAN-FORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019722333

EP Publication Number

3781132

E-Number

1667216

Language

PCT Number

US19027456

Publication Date

24.02.2021 A

20.03.2024 B1

Registration Date

20.03.2024

AT Publication Date

15.04.2024

Application Date

15.04.2019

Registration Number

Priorities

16.04.2018

201862658175 P

IPC

A61K 9/16 20060101AFI20191025BHEP

Maximum Duration of Protection

15.04.2039

Owner

Bristol-Myers Squibb CompanyRoute 206 & Province Line Road Princeton, NJ 08543US

Pfizer Inc.66 Hudson Boulevard East New York, NY 10001-2192US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

BADAWY, Sherif, Ibrahim, Faragc/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ 08543-4000US

STEVENS, Timothy, D.c/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ 08543-4000US

KUNTZ, Danielc/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ 08543-4000US

WAYBRANT, Brettc/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ 08543-4000US

Information about Fees